Trials / Recruiting
RecruitingNCT06487286
Levels of Visfatin/NAMPT in Human Milk
Levels of Visfatin/NAMPT in Human Milk.VISFAMILK
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- Paolo Manzoni Study Group · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Visfatin, released in maternal milk at different concentrations related to the maternal conditions, could act as a biomarker with a prognostic/predictive value to determine different newborn clinical conditions, particularly the weight loss of the neonate.
Detailed description
The aim of the study is to analyse a retrospective cohort of well characterized mothers in their post-partum period, and to measure Visfatin levels through collection of maternal milk samples. They will be collected in three different moments after the birth (48 hours, 7 days and 30 days) and Visfatin levels will be analysed through an ELISA kit Adipogen. In parallel, the levels of Visfatin will be evaluated in the maternal plasma/serum collected after 1-2 days postpartum. Lastly, correlations between Visfatin levels and biological/clinical features of mothers and newborns will be explored.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | observational study | observational study |
Timeline
- Start date
- 2024-10-24
- Primary completion
- 2025-04-23
- Completion
- 2025-04-23
- First posted
- 2024-07-05
- Last updated
- 2024-11-14
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06487286. Inclusion in this directory is not an endorsement.